Arvinas (ARVN) Other Non-Current Assets (2017 - 2026)

Arvinas (ARVN) recorded quarterly Other Non-Current Assets of $3.5 million in Q1 2026, down 7.89% quarter-over-quarter from $3.8 million in Q4 2025, and down 27.08% on a YoY basis from $4.8 million in Q1 2025.

Arvinas (ARVN) Other Non-Current Assets (2017 - 2026) Analysis & Trends

Arvinas' Other Non-Current Assets history runs 10 years deep, the most recent figure standing at $3.5 million for Q1 2026.

  • In Q1 2026, Other Non-Current Assets fell 27.08% year-over-year to $3.5 million; the TTM figure through Mar 2026 stood at $3.5 million (down 27.08% YoY), while the FY2025 annual figure was $3.8 million, down 53.09% from the prior year.
  • Other Non-Current Assets was $3.5 million for Q1 2026 at Arvinas, down from $3.8 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $12.1 million in Q1 2022 to a low of $3.5 million in Q1 2026.
  • Historically, Other Non-Current Assets has averaged $8.6 million across 5 years, with a median of $9.9 million in 2024.
  • The sharpest annual moves came in 2024 and 2025: Other Non-Current Assets gained 14.85% in 2024, then slumped 62.07% in 2025.
  • A 5-year view of Other Non-Current Assets shows it stood at $10.8 million in 2022, then fell by 3.7% to $10.4 million in 2023, then slipped by 22.12% to $8.1 million in 2024, then slumped by 53.09% to $3.8 million in 2025, then dropped by 7.89% to $3.5 million in 2026.
  • The last three Other Non-Current Assets figures came in at $3.5 million (Q1 2026), $3.8 million (Q4 2025), and $3.9 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 289.41 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 12.40 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 60,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 1.26 Bn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Arvinas 492.16 Mn -122.74 Mn - 3.50 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 3.50 Mn
Dec 31, 2025 3.80 Mn
Sep 30, 2025 3.90 Mn
Jun 30, 2025 4.40 Mn
Mar 31, 2025 4.80 Mn
Dec 31, 2024 8.10 Mn
Sep 30, 2024 9.80 Mn
Jun 30, 2024 11.60 Mn
Mar 31, 2024 9.90 Mn
Dec 31, 2023 10.40 Mn
Sep 30, 2023 9.60 Mn
Jun 30, 2023 10.10 Mn
Mar 31, 2023 10.30 Mn
Dec 31, 2022 10.80 Mn
Sep 30, 2022 11.30 Mn
Jun 30, 2022 11.70 Mn
Mar 31, 2022 12.10 Mn
Dec 31, 2021 12.50 Mn
Sep 30, 2021 12.84 Mn
Sep 30, 2020 28,777.00